An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303

Condition:   Lennox Gastaut Syndrome Intervention:   Drug: Rufinamide Sponsor:   Eisai Inc. Available

Source: ClinicalTrials.gov - December 18, 2018 Category: Research Source Type: clinical trials